Biotech’s Next Generational Breakout

An answer to myeloid leukemia could be imminent with over 773 percent potential upside, according to an HC Wainwright Analyst. Take a moment to learn why Actinium Pharmaceuticals might be behind biotech’s next generational leap forward.

Cannabis Company Set to Explode in 2022

The burgeoning cannabis industry is in the middle of an explosion, led at least in part by a company that aims to be a figurehead of the cannabis industry. With the lowest production cost in the industry, this is a stock to watch.